Ronald Pepin Email

SVP and Chief Business Officer . Celldex Therapeutics

Current Roles

Employees:
181
Revenue:
$15M
About
Celldex is an innovative biotechnology company focused on the discovery, development and commercialization of targeted immunotherapies. Our core focus includes the use of tumor-specific targets and human monoclonal antibodies as precision delivered therapeutic agents for the treatment of cancer, infectious diseases and immune system disorders through our novel 'active immunization' approach. We have developed our Antigen Presenting Cell Targeting Technology (APC Targeting Technology™) that utilizes proprietary human monoclonal antibodies to directly target specialized types of immune system cells known as antigen presenting cells, or APCs - particularly dendritic cells. We are using this technology approach to build a substantial pipeline of clinical development candidates that will address significant gaps in the treatment of many specific cancers, as well as within our growing activities in infectious disease and auto-immune disorders
Celldex Therapeutics Address
53 Frontage Road
Hampton, NJ
United States
Celldex Therapeutics Email

Past Companies

Celldex Therapeutics
-
-

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.